Boada, M., Anaya, F., Ortiz, P., Olazarán, J., Shua-Haim, J. R., Obisesan, T. O., . . . Páez, A. (2017). Efficacy and Safety of Plasma Exchange with 5% Albumin to Modify Cerebrospinal Fluid and Plasma Amyloid-β Concentrations and Cognition Outcomes in Alzheimer’s Disease Patients: A Multicenter, Randomized, Controlled Clinical Trial. J Alzheimers Dis.
Citación estilo ChicagoBoada, Mercè, et al. "Efficacy and Safety of Plasma Exchange With 5% Albumin to Modify Cerebrospinal Fluid and Plasma Amyloid-β Concentrations and Cognition Outcomes In Alzheimer’s Disease Patients: A Multicenter, Randomized, Controlled Clinical Trial." J Alzheimers Dis 2017.
Cita MLABoada, Mercè, et al. "Efficacy and Safety of Plasma Exchange With 5% Albumin to Modify Cerebrospinal Fluid and Plasma Amyloid-β Concentrations and Cognition Outcomes In Alzheimer’s Disease Patients: A Multicenter, Randomized, Controlled Clinical Trial." J Alzheimers Dis 2017.